The relationship between the BRAFV600E mutation in papillary thyroid microcarcinoma and clinicopathologic factors
Open Access
- 14 November 2013
- journal article
- research article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 11 (1) , 291
Abstract
The BRAFV600E mutation, which accounts for about 60–80% papillary thyroid carcinoma(PTC), has been identifiedas a prognostic marker for risk stratification of PTC patients. However, the BRAFV600E mutation as a prognostic marker in papillary thyroid microcarcinoma (PTMC) is unclear. We performed a retrospective review of 101 patients who underwent surgery for PTMC. We studied the prevalence of the BRAFV600E mutation. The associations between the BRAFV600E mutation and clinicopathologic characteristics were analyzed. The BRAFV600E mutation was observed in 72 patients (71.3%). There was no statistically significant correlation in age, gender, multifocality, extrathyroidal extension, presence of Hashimoto thyroiditis, and lymph node metastasis between the BRAFV600E mutant group and wild group. The BRAFV600E mutation is not significantly associated with prognostic factors in PTMC.Keywords
This publication has 13 references indexed in Scilit:
- Clinicopathologic Implications of the BRAF V600E Mutation in Papillary Thyroid Cancer: A Subgroup Analysis of 3130 Cases in a Single CenterThyroid®, 2013
- Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid CancerJAMA, 2013
- Reoperative central compartment dissection for patients with recurrent/persistent papillary thyroid cancer: Efficacy, safety, and the association of the BRAF mutationThe Laryngoscope, 2012
- BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinomaAuris Nasus Larynx, 2012
- Analysis of Differential BRAFV600E Mutational Status in High Aggressive Papillary Thyroid MicrocarcinomaAnnals of Surgical Oncology, 2008
- BRAF(V600E) mutation and the biology of papillary thyroid cancerEndocrine-Related Cancer, 2008
- Clinical Features and Therapeutic Implication of Papillary Thyroid MicrocarcinomaThyroid®, 2007
- The BRAFV600E mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinomaClinical Endocrinology, 2005
- High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.2003
- A rationale for conservative management of microscopic papillary carcinoma of the thyroid gland: a clinicopathologic correlation of 90 casesEuropean Archives of Oto-Rhino-Laryngology, 1998